This filing is a technical step toward making the S-1 effective. Monitor for effectiveness and potential future sales by selling securityholders, which could add overhang. No immediate trading catalyst.
Executive Summary
This S-1/A amendment for Presidio Production Company is a purely administrative filing to add consents from independent petroleum engineers (Exhibits 23.4 and 23.5). No changes were made to the prospectus or financials. The filing has no material impact on the company's fundamentals or outlook.
Key Facts
- Amendment No. 1 to Form S-1 filed solely to add Exhibit 23.4 (consent of Cawley, Gillespie & Associates for PIH reserve report dated Feb 2, 2026) and Exhibit 23.5 (consent of same firm for EQVR reserve report dated Jan 8, 2026).
- No changes or additions to the prospectus, expenses, or other sections of the registration statement.
- SEC registration fee for this shelf registration is $3,181.37.
- Recent unregistered issuances include 1,962,240 shares of Class A common stock for the Canyon Creek Acquisition (July 2026).
Financial Impact
No financial impact — administrative filing only.
Risk Factors
- Future share sales by selling securityholders may create downward pressure on FTW stock.
- Potential dilution from outstanding warrants exercisable at $0.01 per share (Series A Preferred warrants for 937,500 shares) and Series A/B preferred stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-086640 |
| Document: ea030102301ex23-4.htm | 0001213900-26-086640 |
| Document: ea030102301ex23-5.htm | 0001213900-26-086640 |
| Document: 0001213900-26-086640-index-headers.html | 0001213900-26-086640 |
| Document: 0001213900-26-086640-index.html | 0001213900-26-086640 |
| Document: 0001213900-26-086640.txt | 0001213900-26-086640 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | EFFECT | $9.96 | awaiting T+20 | — | $10.19 (+2.31%) |
Oct 1, 2026 26d ago | EFFECT | $9.96 | awaiting T+20 | — | $10.19 (+2.31%) |
Aug 17, 2026 10w ago | 8-K | $11.31 $10.21 | ▼ −9.73% | ▼ −7.75% | $10.19 (−9.90%) |
Aug 13, 2026 10w ago | EFFECT | $11.21 $10.45 | ▲ +6.78% | ▲ +5.03% | $10.19 (+9.10%) |
Aug 7, 2026 11w ago | S-1/A | $11.39 $10.63 | ▼ −6.67% | ▼ −5.76% | $10.19 (−10.54%) |
Jun 18, 2026 18w ago | 8-K | $12.57 $12.14 | ▼ −3.42% | ▼ −3.95% | $10.19 (−18.93%) |
May 14, 2026 23w ago | 8-K | — | awaiting T+20 | — | — |
Mar 24, 2026 31w ago | EFFECT | $12.31 $10.69 | ▼ −13.18% | ▼ −22.08% | $10.19 (−17.24%) |
Mar 20, 2026 31w ago | 15-12G | $12.64 $10.70 | ▼ −15.35% | ▼ −22.77% | $10.19 (−19.38%) |
Mar 16, 2026 32w ago | S-1 | $11.90 $10.17 | ▼ −14.52% | ▼ −18.30% | $10.19 (−14.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers